ER7 Fundamental Analysis - ERAMET

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ER7. ER7 was compared to 42 industry peers in the Metals & Mining industry. ER7 may be in some trouble as it scores bad on both profitability and health. ER7 has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

ER7 had negative earnings in the past year.
ER7 had a negative operating cash flow in the past year.
ER7 had positive earnings in 4 of the past 5 years.
Of the past 5 years ER7 4 years had a positive operating cash flow.

1.2 Ratios

ER7's Return On Assets of -1.58% is on the low side compared to the rest of the industry. ER7 is outperformed by 66.67% of its industry peers.
Looking at the Return On Equity, with a value of -9.29%, ER7 is doing worse than 76.19% of the companies in the same industry.
ER7's Return On Invested Capital of 0.80% is on the low side compared to the rest of the industry. ER7 is outperformed by 71.43% of its industry peers.
ER7 had an Average Return On Invested Capital over the past 3 years of 7.29%. This is in line with the industry average of 7.48%.
The 3 year average ROIC (7.29%) for ER7 is well above the current ROIC(0.80%). The reason for the recent decline needs to be investigated.

		Industry Rank	Sector Rank
ROA	-1.58%
ROE	-9.29%
ROIC	0.8%

ROA(3y)4.1%

ROA(5y)1.33%

ROE(3y)16.44%

ROE(5y)-1.91%

ROIC(3y)7.29%

ROIC(5y)7.73%

1.3 Margins

In the last couple of years the Profit Margin of ER7 has declined.
The Operating Margin of ER7 (1.91%) is worse than 64.29% of its industry peers.
ER7's Operating Margin has declined in the last couple of years.
ER7 has a better Gross Margin (68.15%) than 90.48% of its industry peers.
In the last couple of years the Gross Margin of ER7 has grown nicely.

		Industry Rank	Sector Rank
OM	1.91%
PM (TTM)	N/A
GM	68.15%

OM growth 3Y-46.5%

OM growth 5Y-18.83%

PM growth 3Y-61.12%

PM growth 5YN/A

GM growth 3Y-3.21%

GM growth 5Y23.96%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ER7 is destroying value.
ER7 has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ER7 has more shares outstanding
Compared to 1 year ago, ER7 has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.16, we must say that ER7 is in the distress zone and has some risk of bankruptcy.
ER7 has a Altman-Z score of 1.16. This is in the lower half of the industry: ER7 underperforms 73.81% of its industry peers.
ER7 has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
ER7 has a worse Debt to Equity ratio (2.03) than 90.48% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	2.03
Debt/FCF	N/A
Altman-Z	1.16

ROIC/WACC0.08

WACC9.49%

2.3 Liquidity

A Current Ratio of 1.54 indicates that ER7 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.54, ER7 is doing worse than 73.81% of the companies in the same industry.
ER7 has a Quick Ratio of 1.06. This is a normal value and indicates that ER7 is financially healthy and should not expect problems in meeting its short term obligations.
ER7's Quick ratio of 1.06 is on the low side compared to the rest of the industry. ER7 is outperformed by 64.29% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.54
Quick Ratio	1.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ER7 have decreased strongly by -219.63% in the last year.
ER7 shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -64.00% yearly.
Looking at the last year, ER7 shows a decrease in Revenue. The Revenue has decreased by -6.91% in the last year.
ER7 shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.39% yearly.

EPS 1Y (TTM)-219.63%

EPS 3Y-64%

EPS 5YN/A

EPS Q2Q%-268.75%

Revenue 1Y (TTM)-6.91%

Revenue growth 3Y-7.18%

Revenue growth 5Y-4.39%

Sales Q2Q%-3.31%

3.2 Future

The Earnings Per Share is expected to decrease by -44.51% on average over the next years. This is quite bad
Based on estimates for the next years, ER7 will show a small growth in Revenue. The Revenue will grow by 7.00% on average per year.

EPS Next Y-340.43%

EPS Next 2Y-74.62%

EPS Next 3Y-44.51%

EPS Next 5YN/A

Revenue Next Year-0.95%

Revenue Next 2Y5.78%

Revenue Next 3Y7%

Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ER7 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ER7. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

ER7's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	17.97

4.3 Compensation for Growth

ER7's earnings are expected to decrease with -44.51% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-74.62%

EPS Next 3Y-44.51%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ER7 has a Yearly Dividend Yield of 1.98%.
Compared to an average industry Dividend Yield of 1.66, ER7 pays a bit more dividend than its industry peers.
ER7's Dividend Yield is comparable with the S&P500 average which is at 1.92.

		Industry Rank	Sector Rank
Dividend Yield	1.98%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years1

5.3 Sustainability

ER7 has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-44.33%

EPS Next 2Y-74.62%

EPS Next 3Y-44.51%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ERAMET

FRA:ER7 (1/13/2026, 7:00:00 PM)

+2.75 (+3.75%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)10-30 2025-10-30

Earnings (Next)02-17 2026-02-17/amc

Inst Owners15.34%

Inst Owner ChangeN/A

Ins Owners0.17%

Ins Owner ChangeN/A

Market Cap2.19B

Revenue(TTM)2.88B

Net Income(TTM)-97.00M

Analysts52.73

Price Target53.14 (-30.08%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.98%

Yearly Dividend1.51

Dividend Growth(5Y)N/A

DP-44.33%

Div Incr Years0

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)1.94%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-2336.59%

EPS NY rev (3m)-30.76%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-3.86%

Revenue NY rev (3m)-6.63%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.76
P/FCF	N/A
P/OCF	N/A
P/B	2.09
P/tB	4.05
EV/EBITDA	17.97

EPS(TTM)-3.42

EYN/A

EPS(NY)-4.4

Fwd EYN/A

FCF(TTM)-25.76

FCFYN/A

OCF(TTM)-4.59

OCFYN/A

SpS100.31

BVpS36.3

TBVpS18.78

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.58%
ROE	-9.29%
ROCE	1.16%
ROIC	0.8%
ROICexc	0.95%
ROICexgc	1.09%
OM	1.91%
PM (TTM)	N/A
GM	68.15%
FCFM	N/A

ROA(3y)4.1%

ROA(5y)1.33%

ROE(3y)16.44%

ROE(5y)-1.91%

ROIC(3y)7.29%

ROIC(5y)7.73%

ROICexc(3y)10.98%

ROICexc(5y)11.38%

ROICexgc(3y)12.91%

ROICexgc(5y)13.43%

ROCE(3y)10.76%

ROCE(5y)11.32%

ROICexgc growth 3Y-56.22%

ROICexgc growth 5Y-25.38%

ROICexc growth 3Y-55.33%

ROICexc growth 5Y-24.94%

OM growth 3Y-46.5%

OM growth 5Y-18.83%

PM growth 3Y-61.12%

PM growth 5YN/A

GM growth 3Y-3.21%

GM growth 5Y23.96%

F-Score2

Asset Turnover0.47

Health

		Industry Rank	Sector Rank
Debt/Equity	2.03
Debt/FCF	N/A
Debt/EBITDA	10.29
Cap/Depr	403.31%
Cap/Sales	21.11%
Interest Coverage	0.34
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.54
Quick Ratio	1.06
Altman-Z	1.16

F-Score2

WACC9.49%

ROIC/WACC0.08

Cap/Depr(3y)260.42%

Cap/Depr(5y)209.27%

Cap/Sales(3y)18.57%

Cap/Sales(5y)15.29%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-219.63%

EPS 3Y-64%

EPS 5YN/A

EPS Q2Q%-268.75%

EPS Next Y-340.43%

EPS Next 2Y-74.62%

EPS Next 3Y-44.51%

EPS Next 5YN/A

Revenue 1Y (TTM)-6.91%

Revenue growth 3Y-7.18%

Revenue growth 5Y-4.39%

Sales Q2Q%-3.31%

Revenue Next Year-0.95%

Revenue Next 2Y5.78%

Revenue Next 3Y7%

Revenue Next 5YN/A

EBIT growth 1Y-51.75%

EBIT growth 3Y-50.34%

EBIT growth 5Y-22.39%

EBIT Next Year8.9%

EBIT Next 3Y30.86%

EBIT Next 5YN/A

FCF growth 1Y-850%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-121.46%

OCF growth 3YN/A

OCF growth 5YN/A

ERAMET / ER7.DE FAQ

What is the fundamental rating for ER7 stock?

ChartMill assigns a fundamental rating of 2 / 10 to ER7.DE.

Can you provide the valuation status for ERAMET?

ChartMill assigns a valuation rating of 0 / 10 to ERAMET (ER7.DE). This can be considered as Overvalued.

What is the profitability of ER7 stock?

ERAMET (ER7.DE) has a profitability rating of 3 / 10.

Can you provide the financial health for ER7 stock?

The financial health rating of ERAMET (ER7.DE) is 1 / 10.

How sustainable is the dividend of ERAMET (ER7.DE) stock?

The dividend rating of ERAMET (ER7.DE) is 2 / 10 and the dividend payout ratio is -44.33%.

ERAMET (ER7.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

ERAMET / ER7.DE FAQ

What is the fundamental rating for ER7 stock?

Can you provide the valuation status for ERAMET?

What is the profitability of ER7 stock?

Can you provide the financial health for ER7 stock?

How sustainable is the dividend of ERAMET (ER7.DE) stock?